Prima BioMed (IMMP)
(Delayed Data from NSDQ)
$2.63 USD
+0.04 (1.54%)
Updated Sep 12, 2024 04:00 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for Prima BioMed Ltd falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -28.01 | -26.86 | -23.37 | 0.00 | -9.04 |
Depreciation/Amortization & Depletion | 1.48 | 1.39 | 1.50 | 0.00 | 1.40 |
Net Change from Assets/Liabilities | 2.62 | 0.51 | -1.13 | 0.00 | 0.06 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.07 | 1.15 | 1.07 | -13.18 | 0.31 |
Net Cash From Operating Activities | -22.84 | -23.80 | -21.93 | -13.18 | -7.28 |
Property & Equipment | -0.02 | -0.06 | -0.02 | -0.01 | -0.01 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -13.17 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -0.59 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -13.78 | -0.06 | -0.02 | -0.01 | -0.01 |
Uses of Funds
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 65.73 | 53.91 | 38.43 | 40.78 | 14.79 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -0.15 | -0.14 | -0.16 | -0.16 | -0.05 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -3.17 | -2.59 | -1.76 | -1.25 | -0.99 |
Net Cash from Financing Activities | 62.42 | 51.18 | 36.51 | 39.36 | 13.75 |
Effect of Exchange Rate Changes | -0.63 | 1.91 | -0.49 | -0.56 | 0.09 |
Net Change In Cash & Equivalents | 25.16 | 29.23 | 14.08 | 25.61 | 6.55 |
Cash at Beginning of Period | 80.94 | 53.85 | 43.96 | 19.67 | 11.13 |
Cash at End of Period | 106.10 | 83.08 | 58.04 | 45.28 | 17.68 |
Diluted Net EPS | -0.23 | -0.30 | -0.28 | -0.38 | -0.23 |
Fiscal Year End for Prima BioMed Ltd falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -28.01 | NA | NA | NA | -26.86 |
Depreciation/Amortization & Depletion | 1.48 | NA | NA | NA | 1.39 |
Net Change from Assets/Liabilities | 2.62 | NA | NA | NA | 0.52 |
Net Cash from Discontinued Operations | NA | NA | NA | NA | 0.00 |
Other Operating Activities | 1.08 | NA | -12.02 | NA | 1.15 |
Net Cash From Operating Activities | -22.84 | NA | -12.02 | NA | -23.80 |
Property & Equipment | -0.02 | NA | -0.01 | NA | -0.06 |
Acquisition/ Disposition of Subsidiaries | NA | NA | NA | NA | 0.00 |
Investments | -13.17 | NA | -0.06 | NA | 0.00 |
Other Investing Activities | -0.59 | NA | -0.21 | NA | 0.00 |
Net Cash from Investing Activities | -13.78 | NA | -0.27 | NA | -0.06 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 65.73 | NA | NA | NA | 53.91 |
Issuance (Repayment) of Debt | NA | NA | NA | NA | 0.00 |
Increase (Decrease) Short-Term Debt | -0.15 | NA | -0.08 | NA | -0.14 |
Payment of Dividends & Other Distributions | NA | NA | NA | NA | 0.00 |
Other Financing Activities | -3.17 | NA | -0.20 | NA | -2.59 |
Net Cash from Financing Activities | 62.42 | NA | -0.28 | NA | 51.18 |
Effect of Exchange Rate Changes | -0.64 | NA | -0.25 | NA | 1.91 |
Net Change In Cash & Equivalents | 25.17 | NA | -12.83 | NA | 29.23 |
Cash at Beginning of Period | 80.94 | NA | 80.42 | NA | 53.85 |
Cash at End of Period | 106.10 | NA | 67.59 | NA | 83.09 |
Diluted Net EPS | NA | NA | NA | NA | NA |